Consumers who choose a 2017 TOP SAFETY PICK+ award winner shouldn’t have trouble seeing the road on nighttime drives. Good or acceptable ratings in the Insurance Institute for Highway Safety’s new headlight evaluations set the latest crop of qualifiers apart. Thirty-eight models earn the “plus” accolade, and 44 earn TOP SAFETY PICK.
IIHS toughened the criteria for TOP SAFETY PICK+ to reflect new headlight evaluations launched in 2016. The recognition program is meant to encourage manufacturers to offer state-of-the-art protection for people in crashes, along with features that help drivers avoid crashes in the first place. In addition to good or acceptable headlights, the latter includes automatic braking technology, which has been part of the criteria since 2015.
For both awards, models must earn good ratings in the Institute’s small overlap front, moderate overlap front, side, roof strength and head restraint tests, as well as an advanced or superior rating for front crash prevention with standard or optional autobrake. Headlights are factored in only for the top award.
Two all-electric vehicles fall short of meeting the Insurance Institute for Highway Safety’s awards criteria, but consumers who want to minimize gas consumption while also prioritizing safety can choose from two plug-in hybrids that earn the 2017 TOP SAFETY PICK+ award.
The two recently evaluated all-electric models are the 2017 Tesla Model S and the 2017 BMW i3. The plug-in hybrid models are the Chevrolet Volt, whose award was announced in December, and the Toyota Prius Prime.
To qualify for the 2017 TOP SAFETY PICK award, a vehicle must earn good ratings in all five crashworthiness evaluations — small overlap front, moderate overlap front, side, roof strength and head restraints — and come with a front crash prevention system that earns an advanced or superior rating. The “plus” is awarded to vehicles that meet all those criteria and also come with good or acceptable headlights.
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
The U.S. Food and Drug Administration (FDA) is alerting pregnant women about the risks of listeriosis, a foodborne disease that can severely affect a pregnant women and her unborn child.
Listeria can affect all races and ethnic groups, but pregnant women are 10 times more likely than other healthy adults to get listeriosis due to hormonal changes that affect the immune system during pregnancy. Pregnant Hispanic women are about 24 times more likely than the general population to get listeriosis. A pregnant mother may pass Listeria onto her unborn baby without even knowing it because she doesn’t feel sick at all, yet the disease can lead to miscarriage, stillbirth, premature labor, the delivery of a low birthweight infant, a wide range of health problems for a newborn, or even infant death.
To view the multimedia release go to:
https://www.multivu.com/players/English/7953451-fda-listeriosis-prevention-pregnant-women/
La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) alerta a las mujeres embarazadas sobre los riesgos de la listeriosis, una enfermedad transmitida por los alimentos que puede afectar gravemente a las mujeres embarazadas y a sus bebés no nacidos.
La Listeria puede afectar a personas de todas las razas y grupos étnicos, pero las mujeres embarazadas tienen una probabilidad aproximadamente 10 veces mayor de contraer listeriosis que otros adultos sanos debido a los cambios hormonales que afectan el sistema inmunológico durante el embarazo. Las mujeres hispanas embarazadas son unas 24 veces más propensas a contraer listeriosis que la población general. Una mujer embarazada puede transmitir la Listeria a su bebé no nacido incluso sin saberlo porque no se siente enferma, pero la enfermedad puede provocar un aborto espontáneo, muerte fetal, parto prematuro, nacimiento de un bebé con bajo peso, una amplia gama de problemas de salud para el recién nacido o incluso la muerte del bebé.
To view the multimedia release go to:
https://www.multivu.com/players/Spanish/7953451-fda-listeriosis-prevention-pregnant-women/
Jason’s Deli and The University of Texas MD Anderson Cancer Center proudly introduce the new Salmon Pacifica Salad as part of an ongoing alliance to raise money to help end cancer for patients and families around the world.
Now through April 2018, 50 cents from the sale of every Salmon Pacifica Salad at participating Jason’s Deli restaurants will be donated to MD Anderson to support cancer prevention research and programs.
To view the multimedia release go to:
https://www.multivu.com/players/English/8102251-jasons-deli-md-anderson-cancer-center-salmon-pacifica-salad/
The Lincoln Continental, the Mercedes-Benz E-Class and the Toyota Avalon come out at the top of a group of six large cars recently evaluated by the Insurance Institute for Highway Safety.
The three cars qualify for TOP SAFETY PICK+, the Institute’s highest award. The Tesla Model S, the Chevrolet Impala and the Ford Taurus fall short of any award because they each earn only an acceptable rating in the small overlap front test.
Vehicles qualify for either the TOP SAFETY PICK or TOP SAFETY PICK+ award if they have good ratings from IIHS in five crashworthiness tests — small overlap front, moderate overlap front, side, roof strength and head restraints — and an available front crash prevention system that earns a superior or advanced rating. To qualify for TOP SAFETY PICK+, a vehicle also must come with good or acceptable headlights
TriggerPoint™, the market leader in foam rolling, movement products and education, today announces the launch of the GRID VIBE premium vibrating foam roller. Designed for muscle relaxation and pain reduction, the GRID VIBE pairs TriggerPoint’s patented GRID foam roller design with vibration technology to deliver enhanced muscle mobility experiences.
The GRID VIBE’s vibration frequency is specifically calibrated at 33 hertz for optimal muscle relaxation, minimizing discomfort and allowing users to focus longer on foam rolling tender areas. Research shows that vibration decreases the body’s sensation of pain. When vibration is paired with TriggerPoint’s signature GRID pattern that mimics a massage therapist’s hands, fingers and fingertips, the GRID VIBE effectively targets more layers of tight muscle tissue. The GRID VIBE can be used by anyone for muscle recovery, injury prevention, improving athletic performance, pain management, or boosting overall body movement and mobility.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135751-triggerpoint-grid-vibe-vibrating-foam-roller/
TriggerPoint™, the market leader in foam rolling, movement products and education, today announces the launch of the GRID VIBE premium vibrating foam roller. Designed for muscle relaxation and pain reduction, the GRID VIBE pairs TriggerPoint’s patented GRID foam roller design with vibration technology to deliver enhanced muscle mobility experiences.
The GRID VIBE’s vibration frequency is specifically calibrated at 33 hertz for optimal muscle relaxation, minimizing discomfort and allowing users to focus longer on foam rolling tender areas. Research shows that vibration decreases the body’s sensation of pain. When vibration is paired with TriggerPoint’s signature GRID pattern that mimics a massage therapist’s hands, fingers and fingertips, the GRID VIBE effectively targets more layers of tight muscle tissue. The GRID VIBE can be used by anyone for muscle recovery, injury prevention, improving athletic performance, pain management, or boosting overall body movement and mobility.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135751-triggerpoint-grid-vibe-vibrating-foam-roller/
October is National Bullying Prevention Month, providing a national spotlight on an important issue facing a reported one in five kids: bullying. PACER’s National Bullying Prevention Center, the preeminent bullying prevention charity in the nation, is on a mission to drive social change that ends bullying. The organization works to put important resources in the hands of parents, educators and students alike, working to ensure that bullying is no longer an accepted childhood rite of passage. Today PACER and Clarisonic®, the creator of the #1 most-recommended skin-cleansing device by U.S. dermatologists*, announce a new partnership and campaign designed to drive awareness and raise donations for PACER’s bullying prevention efforts. For every #CleanTheMean social post shared on Facebook or Instagram this year, Clarisonic will donate $1 to PACER’s National Bullying Prevention Center, up to $100,000.
To view the multimedia release go to:
https://www.multivu.com/players/English/8191651-clarisonic-pacer-stop-bullying-cleanthemean-campaign/
As back to school season approaches, Pilot Corporation of America (Pilot Pen) is working diligently to help empower students to excel and to overcome their greatest challenges during the school year. Bullying and cyberbullying are at an all time high, with nearly 1 out of 4 U.S. students having been bullied. Pilot Pen’s ongoing partnership with the nation’s leading anti-bullying prevention organization, STOMP Out Bullying is designed to help “Erase Bullying For Good,” for the fourth consecutive year. The goal of this campaign is to raise awareness of this serious issue, helping to ensure that parents, educators and students are aware of the valuable resources available to those in need of support. As part of the effort, Pilot is donating 10 cents from every specially-marked package of FriXion Clicker erasable gel ink pens purchased during the back to school period, to support STOMP Out Bullying. Pilot is committed to donating $325,000 to the organization.
To view the multimedia release go to:
https://www.multivu.com/players/English/8342451-pilot-pen-stomp-out-erase-bullying-for-good/
The National Meningitis Association (NMA) today announced the launch of a new educational initiative in collaboration with Sanofi Pasteur, the vaccines division of Sanofi, about the importance of the Centers for Disease Control and Prevention’s (CDC’s) recommended second dose of the meningococcal meningitis vaccine (MenACWY) for adolescents at age 16. The 16 Vaccine (The16Vaccine.org) aims to educate parents about the importance of this critical second dose of MenACWY, which helps protect teens against meningococcal meningitis during the period when they are at increased risk.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385951-national-meningitis-association-the-16-vaccine/
